RBFOX3 and Wilson disease: We then estimated the percentage of BrdU+NeuN+/BrdU+ cells in the DG, our data indicated that the WD group showed a significant reduction in the percentage of co-labeled cells as compared to controls (WD: 17.7%, IQR 10.5–22.5% vs. controls 40.4%, IQR 39.3–40.9%; U = 0, P = 0.004).